NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
Key Details
- 1NCCN updated guidelines to recommend AI-based 5-year breast cancer risk assessment using routine mammograms.
- 2Patients with an AI-predicted 5-year risk ≥1.7% should be considered for supplemental imaging (MRI or ultrasound).
- 3Risk evaluations should begin at age 35, earlier than the previous standard of 40.
- 4Re-assessment over time is advised due to changes in breast tissue.
- 5The Clairity Breast platform, FDA-cleared for this purpose, is highlighted and is reportedly over 3x more accurate at risk prediction than density reporting by radiologists.
Why It Matters
These recommendations will likely accelerate adoption of AI tools in breast imaging, standardizing risk stratification and personalized screening. Radiologists and imaging providers must prepare for new workflows and patient stratification protocols based on AI outputs.
Source
Radiology Business
Related News
•Radiology Business
SimonMed Imaging Introduces Paid AI Add-Ons for Routine Exams
SimonMed Imaging is launching new AI-powered elective services for routine imaging exams with additional out-of-pocket costs for patients.
•Radiology Business
ACR Approves New Framework for Assessing Imaging AI in Practice
The American College of Radiology Council has approved a new practice parameter to guide the assessment and deployment of AI in imaging.
•AuntMinnie
AI in Radiology: Augmentation, Not Replacement – Risks and Realities Reviewed
AI is reshaping radiology workflows but is not ready to replace radiologists, as judgment, accountability, and clinical complexity remain unmet by current technology.